2023Q1营收下滑27.5%,营业利润下滑40%,净利润下滑42.4%。
整体看来和 $越...查看全文
珠海股怪2023-05-05 22:11
回复@随机待缘: 亘喜生物(GRCL)$BCMA/CD19双靶点FasTCAR-T细胞(GC012F)疗效、安全性非常惊艳
2022年12月10~13日,第64届美国血液学年会(ASH)在美国路易斯安那州新奥尔良隆重召开,作为全球血液领域中规模最大和内容最为全面的血液学顶级学术盛会,本届AS...查看全文
$AMN医疗服务(AMN)$ 内部交易: 2020-01-04,Chief Legal Officer,Jackson Denise L ,期权,1216普通股, $0.00
$AMN医疗服务(AMN)$ 内部交易: 2020-01-03,Chief Legal Officer,Jackson Denise L ,期权,1339普通股, $0.00
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-002443 Size: 7 KB 网页链接
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-002431 Size: 26 KB 网页链接
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-002416 Size: 26 KB 网页链接
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-002414 Size: 28 KB 网页链接
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-061991 Size: 4 KB 网页链接
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-061066 Size: 11 KB 网页链接
$AMN医疗服务(AMN)$ 内部交易: 2019-12-05,总裁 and CEO,SALKA SUSAN R ,期权,9872普通股, $0.00
$AMN医疗服务(AMN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059660 Size: 10 KB 网页链接